Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: A study of the Hoosier Oncology Group

Autor: Sayar, Hamid, Chan, Rebecca J., Orschell, Christie M., Chan, Edward M., Yu, Zhangsheng, Hood, Daniel, Plett, Artur, Yang, Zhenyun, Hui, Chua Lin, Nabinger, Sarah C., Kohlbacher, Kristopher J., West, Evan S., Walter, Amanda, Sampson, Carol, Wu, Jingwei, Cripe, Larry D.
Zdroj: In Leukemia Research August 2011 35(8):1108-1110
Databáze: ScienceDirect
Externí odkaz: